ENTRESTO 15 mg/1

ENTRESTO 15 mg/1 is a combination of sacubitril and valsartan, used for managing heart failure. This oral pellet formulation supports cardiovascular health and is manufactured by Novartis Pharmaceuticals Corporation.

ENTRESTO 15 mg/1 is primarily used to treat heart failure, helping to improve heart function and reduce symptoms. It works by relaxing blood vessels and reducing the workload on the heart. This medication is often prescribed for long-term management of heart failure, aiming to enhance quality of life and overall cardiovascular health.

Common effects of ENTRESTO 15 mg/1 may include dizziness, low blood pressure, and cough. Some users might experience fatigue or kidney problems. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

ENTRESTO 15 mg/1 should be handled with care, especially for individuals with a history of angioedema or kidney issues. It is crucial to follow the prescribed dosage and administration guidelines. Regular check-ups are recommended to monitor heart function and overall health.

ENTRESTO 15 mg/1 may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), lithium, and diuretics. Alcohol consumption should be moderated, as it can enhance the effects of the medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.